JPS6250450B2 - - Google Patents

Info

Publication number
JPS6250450B2
JPS6250450B2 JP51097402A JP9740276A JPS6250450B2 JP S6250450 B2 JPS6250450 B2 JP S6250450B2 JP 51097402 A JP51097402 A JP 51097402A JP 9740276 A JP9740276 A JP 9740276A JP S6250450 B2 JPS6250450 B2 JP S6250450B2
Authority
JP
Japan
Prior art keywords
gangliosides
day
patients
group
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP51097402A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5234912A (en
Inventor
Uetsukia Ruiiji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Publication of JPS5234912A publication Critical patent/JPS5234912A/ja
Publication of JPS6250450B2 publication Critical patent/JPS6250450B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP51097402A 1975-08-13 1976-08-13 Extraction of ganglioside and application of same to new medicines Granted JPS5234912A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT26323/75A IT1046051B (it) 1975-08-13 1975-08-13 Nuova applicazione terapeutica dei gangliosidi e procedimento per la loro estrazione

Publications (2)

Publication Number Publication Date
JPS5234912A JPS5234912A (en) 1977-03-17
JPS6250450B2 true JPS6250450B2 (en, 2012) 1987-10-24

Family

ID=11219226

Family Applications (2)

Application Number Title Priority Date Filing Date
JP51097402A Granted JPS5234912A (en) 1975-08-13 1976-08-13 Extraction of ganglioside and application of same to new medicines
JP62000347A Granted JPS62187412A (ja) 1975-08-13 1987-01-05 ガングリオシツドの抽出法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP62000347A Granted JPS62187412A (ja) 1975-08-13 1987-01-05 ガングリオシツドの抽出法

Country Status (7)

Country Link
JP (2) JPS5234912A (en, 2012)
AT (1) AT352296B (en, 2012)
BE (1) BE843695A (en, 2012)
DE (1) DE2549680A1 (en, 2012)
ES (1) ES441233A1 (en, 2012)
FR (1) FR2320760A1 (en, 2012)
IT (1) IT1046051B (en, 2012)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0016702B1 (fr) * 1979-03-16 1985-02-20 Institut Merieux Médicament, notamment pour le traitement du choléra, et compositions pharmaceutiques le contenant
FR2451194A1 (fr) * 1979-03-16 1980-10-10 Merieux Inst Nouveau medicament a base de ganglioside notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant
CA1168980A (en) * 1980-04-17 1984-06-12 Rolf Schafer Wound healing compositions
US4464360A (en) * 1980-05-09 1984-08-07 Hakon Leffler Glycosphingalipids for inhibiting bacterial adherence
EP0126817B1 (en) * 1983-05-27 1989-04-19 Shanksville Corporation N.V. Suppressing of graft rejection in organ transplantation
JPS59222424A (ja) * 1983-06-01 1984-12-14 Katsutaka Nagai 神経障害疾患治療剤
IT1177863B (it) * 1984-07-03 1987-08-26 Fidia Farmaceutici Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche
JPH01228997A (ja) * 1988-03-10 1989-09-12 Mect Corp シアロシルグリセライド類及びその製造方法
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
AR241751A1 (es) * 1989-07-12 1992-12-30 Beta Lab Sa Procedimiento para obtener mezclas de gangliosidos para el tratamiento de enfermedades psico-organicas y del caracter.
IT1232176B (it) 1989-07-27 1992-01-25 Fidia Farmaceutici Derivati di-lisogangliosidi
IT1238346B (it) * 1989-11-14 1993-07-13 Gangliosidi modificati e loro derivati funzionali.
JPH0580009A (ja) * 1991-09-20 1993-03-30 Kubota Corp 炭酸濃度測定方法
JPH0580010A (ja) * 1991-09-25 1993-03-30 Kubota Corp 気体中の炭酸ガス濃度測定方法
RU2195296C2 (ru) * 2000-04-12 2002-12-27 Ставропольский научно-исследовательский противочумный институт Способ получения ганглиозидов
RU2192871C2 (ru) * 2000-11-22 2002-11-20 Нижегородское государственное предприятие по производству бактерийных препаратов - ИмБио Способ получения биологически активного комплекса из животного сырья для терапевтического использования
JP4005115B1 (ja) * 2007-02-08 2007-11-07 日本臓器製薬株式会社 疼痛疾患治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT127981B (de) * 1929-06-07 1932-04-25 Schering Kahlbaum Ag Verfahren zur Herstellung eines die zentralen Tätigkeiten fördernden und regulierenden Reizstoffes.
CH193176A (de) * 1936-12-08 1937-09-30 Richter Arthur Verfahren zur Gewinnung eines Wirkstoffes aus Säugetiergehirn.
US3436413A (en) * 1965-12-21 1969-04-01 Canada Packers Ltd Process for the isolation of phosphatidyl serine

Also Published As

Publication number Publication date
IT1046051B (it) 1980-06-30
JPS6256134B2 (en, 2012) 1987-11-24
FR2320760A1 (fr) 1977-03-11
AT352296B (de) 1979-09-10
FR2320760B1 (en, 2012) 1978-11-17
DE2549680A1 (de) 1977-02-24
ATA606976A (de) 1979-02-15
BE843695A (fr) 1976-11-03
JPS62187412A (ja) 1987-08-15
DE2549680C2 (en, 2012) 1988-05-11
JPS5234912A (en) 1977-03-17
ES441233A1 (es) 1977-03-16

Similar Documents

Publication Publication Date Title
JPS6250450B2 (en, 2012)
Egger et al. Mitochondrial cytopathy. A multisystem disorder with ragged red fibres on muscle biopsy.
Harding et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation
Awadzi et al. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis
KASS et al. Toxoplasmosis in the human adult
US6165515A (en) Method for treatment of osteoporosis
Todorov et al. Albendazole treatment of multiple cerebral hydatid cysts: case report
JPH0776179B2 (ja) 免疫学的因子を含む病気の治療用組成物
Harris et al. Septo-optic dysplasia with growth hormone deficiency (De Morsier syndrome)
JPS63502591A (ja) リユ−マチ様関節炎の治療のための方法と物質
EP0140998B1 (en) Ophthalmic preparations
Wilkinson Feline cryptococcosis: a review and seven case reports
JP2022504771A (ja) 健康寿命延長を目的とするニコチンアミドリボシド組成物
DE69902127T2 (de) Histon beinhaltende zusammenstellung zur behandlung von rheumatischer arthritis
JPH0228119A (ja) 糖尿病性神経障害治療剤
CZ181193A3 (en) Pharmaceutical preparation in the form of a solution for local administration in eye, the use and preparation method thereof
KNUTSON et al. The central nervous system in uremia: a clinicopathologic study
STRAUSS et al. Intramuscular Use of Liver Extract: Maximal Responses of Reticulocytes from Daily Intramuscular Injection of Extract Derived from Ten Grams of Liver: Preliminary Communication
JPH08225452A (ja) 知覚異常改善剤
Hartman Studies on the function and clinical use of cortin
RU2477637C2 (ru) Способ лечения острого нарушения мозгового кровообращения ишемического и геморрагического характера
Inagaki et al. Relief of chronic burning pain in Fabry disease with neurotropin
GB2092001A (en) Pharmaceutical preparations comprising sodium fructose-1, 6-diphosphate for treatment of burn patients
RU2095067C1 (ru) Способ стимуляции репаративных и трофических процессов в тканях организма
JP3813808B2 (ja) ケフィアを用いた糖尿病治療剤の製造方法